ANAB Market Cap History
Below is a table of the ANAB market cap history going back to 1/26/2017:

Date ANAB Market Cap
1/26/2017308.71M
2/28/2017481.14M
5/9/2017523.15M
8/8/2017437.97M
11/3/20171.53B
2/28/20182.92B
5/4/20182.20B
8/3/20181.81B
11/6/20182.15B
2/25/20191.88B
5/3/20191.98B
8/5/20191.36B
11/5/20191.05B
2/27/2020398.07M
5/4/2020496.99M

Also see: ANAB Shares Outstanding History
and ANAB YTD Return
ANAB Historical Market Cap:
+15.68% CAGR
ANAB Historical Market Cap: +15.68% CAGR

Mouse over chart for data details
1/26/2017 ...5/4/2020
AnaptysBio is a clinical stage biotechnology company developing antibody product candidates. Etokimab, Co.'s anti-IL-33 antibody drug candidate, inhibits the activity of the interleukin-33 cytokine that is applicable to the treatment of atopic inflammatory disorders, such as moderate-to-severe atopic dermatitis, eosinophilic asthma, chronic rhinosinusitis with nasal polyps, and potentially other allergic conditions. ANB019 inhibits the interleukin-36 receptor, for the treatment of rare inflammatory diseases including generalized pustular psoriasis and palmoplantar pustulosis. Co.'s wholly-owned pipeline includes anti-inflammatory checkpoint receptor modulator antibodies. We show 15 historical shares outstanding datapoints in our ANAB shares outstanding history coverage, used to compute ANAB market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ANAB market cap history over the course of time is important for investors interested in comparing ANAB's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ANAB versus a peer is one thing; comparing ANAB market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ANAB can fluctuate over the course of history. With this page we aim to empower investors researching ANAB by allowing them to research the ANAB market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ANAB:
ANAB SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
AnaptysBio (ANAB) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ANGO Market Cap History
ANIK Market Cap History
ANIP Market Cap History
ANTH Market Cap History
APEN Market Cap History
APLS Market Cap History
APRI Market Cap History
APVO Market Cap History
AQB Market Cap History
AQXP Market Cap History
More Healthcare companies »

 

ANAB Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2020, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.